MedPath

Mild Head Trauma in the Emergency Room: Assessment of the Risk of Intracranial Hemorrhage in Patients Receving Platelet Inhibitors.

Recruiting
Conditions
Head Trauma Injury
Registration Number
NCT05589103
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

The clinical signs presented by a patient with a mild head injury are highly variable but remain strongly predictive of brain damage. The reference examination for the diagnosis of post-traumatic intracranial hemorrhage is currently the cerebral scanner without injection of contrast medium. Magnetic resonance imaging (MRI) tends to surpass CT in equipped centers, except for suspected bone lesions. The time required to perform brain imaging depends on the patient's clinical condition, comorbidities and treatments.

The responsibility of antiplatelet agents in post-traumatic intracranial hemorrhage is currently discussed, particularly with aspirin.

The hypothesis is that there is no significant difference in the proportion of intracranial hemorrhage in patients on antiplatelet agents after mild head trauma, in the absence of other factors favoring the occurrence of intracranial hemorrhage.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1692
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Propensity score on the factors influencing the taking of antiplatelet agents.Files analysed retrospectively from January 01, 2017 to December 31, 2017 will be examined
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service d'accueil des urgences - CHU de Strasbourg - France

🇫🇷

Strasbourg, France

Service d'accueil des urgences - CHU de Strasbourg - France
🇫🇷Strasbourg, France
Florent BAICRY, MD
Principal Investigator
Quentin DELLENBACH, MD
Sub Investigator
Pierrick LE BORGNE, MD
Sub Investigator
Pascal BILBAULT, MD, PhD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.